{"parse":{"title":"Polypharmacy","pageid":1099391,"revid":844625015,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Methylphenidat_generics_germany.jpg\" class=\"image\"><img alt=\"Methylphenidat generics germany.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Methylphenidat_generics_germany.jpg/220px-Methylphenidat_generics_germany.jpg\" width=\"220\" height=\"147\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/00/Methylphenidat_generics_germany.jpg/330px-Methylphenidat_generics_germany.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/00/Methylphenidat_generics_germany.jpg/440px-Methylphenidat_generics_germany.jpg 2x\" data-file-width=\"4000\" data-file-height=\"2667\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Methylphenidat_generics_germany.jpg\" class=\"internal\" title=\"Enlarge\"></a></div></div></div></div>\n<p><b>Polypharmacy</b> is the concurrent use of multiple <a href=\"/wiki/Pharmaceutical_drug\" class=\"mw-redirect\" title=\"Pharmaceutical drug\">medications</a> by a <a href=\"/wiki/Patient\" title=\"Patient\">patient</a>.<sup id=\"cite_ref-ncbi.nlm.nih.gov_1-0\" class=\"reference\"><a href=\"#cite_note-ncbi.nlm.nih.gov-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-vumc.nl_2-0\" class=\"reference\"><a href=\"#cite_note-vumc.nl-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> Polypharmacy is most common in the <a href=\"/wiki/Elderly\" class=\"mw-redirect\" title=\"Elderly\">elderly</a>, affecting about 40% of older adults living in their own homes.<sup id=\"cite_ref-pmid18184532_5-0\" class=\"reference\"><a href=\"#cite_note-pmid18184532-5\">&#91;5&#93;</a></sup> About 21% of adults with <a href=\"/wiki/Intellectual_disability\" title=\"Intellectual disability\">intellectual disability</a> are also exposed to polypharmacy.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> Polypharmacy is not necessarily ill-advised, but in many instances can lead to negative outcomes or poor treatment effectiveness, often being <a href=\"/wiki/Primum_non_nocere\" title=\"Primum non nocere\">more harmful than helpful</a> or presenting <a href=\"/wiki/Risk%E2%80%93benefit_ratio\" title=\"Risk\u2013benefit ratio\">too much risk for too little benefit</a>. Therefore, <a href=\"/wiki/Health_professional\" title=\"Health professional\">health professionals</a> consider it a situation that requires monitoring and review to validate whether all of the medications are still necessary. Concerns about polypharmacy include increased <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug reactions</a>, <a href=\"/wiki/Drug_interaction\" title=\"Drug interaction\">drug interactions</a>, <a href=\"/wiki/Prescribing_cascade\" class=\"mw-redirect\" title=\"Prescribing cascade\">prescribing cascade</a>, and higher costs.<sup id=\"cite_ref-pmid19054196_7-0\" class=\"reference\"><a href=\"#cite_note-pmid19054196-7\">&#91;7&#93;</a></sup> Polypharmacy is often <a href=\"/wiki/Correlation_and_dependence\" title=\"Correlation and dependence\">associated with</a> a decreased <a href=\"/wiki/Quality_of_life\" title=\"Quality of life\">quality of life</a>, including decreased <a href=\"/wiki/Activities_of_daily_living\" title=\"Activities of daily living\">mobility</a> and <a href=\"/wiki/Cognition\" title=\"Cognition\">cognition</a>.<sup id=\"cite_ref-vumc.nl_2-1\" class=\"reference\"><a href=\"#cite_note-vumc.nl-2\">&#91;2&#93;</a></sup>\n</p><p>The definition of polypharmacy is still debated.  Definitions have ranged from two medications at a time to 18, or to more medications than clinically necessary.  Five or more concurrent regular medications appears to be the most common definition. Despite the uncertainty around a definition, experts generally agree on the magnitude, potential for harm and potential for reduction in medication regimens for older people.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p><p>Whether or not the advantages of polypharmacy (over monotherapy) outweigh the disadvantages or risks depends upon the particular combination and diagnosis involved in any given case.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> The use of multiple drugs, even in fairly straightforward illnesses, is not an indicator of poor treatment and is not necessarily <a href=\"/wiki/Overmedication\" title=\"Overmedication\">overmedication</a>. A perfectly legitimate treatment regimen could include, for example, the following: a <a href=\"/wiki/Statin\" title=\"Statin\">statin</a>, an <a href=\"/wiki/ACE_inhibitor\" title=\"ACE inhibitor\">ACE inhibitor</a>, a <a href=\"/wiki/Beta-blocker\" class=\"mw-redirect\" title=\"Beta-blocker\">beta-blocker</a>, <a href=\"/wiki/Aspirin\" title=\"Aspirin\">aspirin</a>, <a href=\"/wiki/Paracetamol\" title=\"Paracetamol\">paracetamol</a> and an <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a> in the first year after a <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">myocardial infarction</a>.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> Moreover, it is well accepted in <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacology</a> that it is impossible to accurately predict the side effects or clinical effects of a combination of drugs without studying that particular combination of drugs in test subjects. Knowledge of the pharmacologic profiles of the individual drugs in question does not assure accurate prediction of the side effects of combinations of those drugs; and effects also vary among individuals because of <a href=\"/wiki/Genome\" title=\"Genome\">genome</a>-specific <a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">pharmacokinetics</a>. Therefore, deciding whether and how to reduce a list of medications (<a href=\"/wiki/Deprescribing\" title=\"Deprescribing\">deprescribe</a>) is often not simple and requires the experience and judgment of a practicing physician. However, such thoughtful and wise review is an ideal that too often does not happen, owing to problems such as poorly handled <a href=\"/wiki/Transitional_care\" title=\"Transitional care\">care transitions</a> (poor continuity of care, usually because of <a href=\"/wiki/Information_silo\" title=\"Information silo\">siloed information</a>), overworked physicians, and <a href=\"/wiki/Interventionism_(medicine)\" title=\"Interventionism (medicine)\">interventionism</a>.\n</p><p>Polypharmacy continues to grow in importance because of <a href=\"/wiki/Population_ageing\" title=\"Population ageing\">aging populations</a>. Many countries are experiencing a fast growth of the older population, 65 years and older.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> This growth is a result of the <a href=\"/wiki/Baby-boomer\" class=\"mw-redirect\" title=\"Baby-boomer\">baby-boomer</a> generation getting older and an increased <a href=\"/wiki/Life_expectancy\" title=\"Life expectancy\">life expectancy</a> as a result of ongoing improvement in health care services worldwide.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Contraindications\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Contraindications</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Special_populations\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Special populations</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Pill_burden\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Pill burden</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Interventions\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Interventions</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Further_reading\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Considerations often associated with thoughtful, therapeutic polypharmacy include:\n</p>\n<ol><li>Drugs given for a single somatic locale act on biochemical mechanisms present throughout the body such that their nonlinear interactions can produce an (unknown except empirically) global physiological state of health;<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup></li>\n<li>The more independent variables, \"handles\", to manipulate, the greater the likelihood of finding and stabilizing a small available parametric space of healthy function while minimizing unwanted effects.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup></li></ol>\n<p>Often certain medications can interact with others in a positive way specifically intended when prescribed together, to achieve a greater effect that any of the single agents alone. This is particularly prominent in the field of anesthesia and pain management \u2013 where atypical agents such as antiepileptics, antidepressants, muscle relaxants, NMDA antagonists, and other medications are combined with more typical analgesics such as opioids, prostaglandin inhibitors, NSAIDS and others. This practice of pain management drug synergy is known as an <i>analgesia sparing</i> effect.\n</p><p>As another example, in anesthesia (particularly IV anesthesia and general anesthesia) multiple agents are almost always required \u2013 including hypnotics or analgesic inducing/maintenance agents such as Versed or Diprivan, usually an opioid analgesic such as morphine or Demerol, a paralytic such as vecuronium, and in inhaled general anesthesia generally a halogenated ether anesthetic such as sevoflurane or desflurane.\n</p>\n<h2><span class=\"mw-headline\" id=\"Contraindications\">Contraindications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=2\" title=\"Edit section: Contraindications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The use of polypharmacy is correlated to the use of potentially inappropriate medications. Potentially inappropriate medications are generally taken to mean those that have been agreed upon by expert consensus, such as by the <a href=\"/wiki/Beers_Criteria\" title=\"Beers Criteria\">Beers Criteria</a>. These medications are generally inappropriate for older adults because the risks outweigh the benefits. Examples of these include urinary anticholinergics, which can prevent up to one episode of incontinence every 48 hours on average. However, they can also cause constipation, dry eyes, dry mouth, impaired cognition, and increase the risk of falls.\n</p><p>Polypharmacy is associated with an increased risk of falls in the elderly. Certain medications are well known to be associated with the risk of falls, including cardiovascular and psychoactive medications. The use of four or more of these medicines is known to be associated with a significantly higher, cumulative risk of falls. Although often not practical to achieve, withdrawing all medicines associated with falls risk can halve an individual's risk of future falls.\n</p><p>Every medication has potential adverse side-effects. With every drug added, there is an additive risk of side-effects. Also, many medications have potential <a href=\"/wiki/Drug_interaction\" title=\"Drug interaction\">interactions</a> with other substances. 15% of older adults are potentially at risk for a major drug-drug interaction.<sup id=\"cite_ref-PMC2702513_17-0\" class=\"reference\"><a href=\"#cite_note-PMC2702513-17\">&#91;17&#93;</a></sup> When a new drug is prescribed, the risk of interactions increases exponentially. Doctors and <a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">pharmacists</a> aim to avoid prescribing medications that interact; often, adjustments in the dose of medications need to be made to avoid interactions, such as with <a href=\"/wiki/Warfarin\" title=\"Warfarin\">warfarin</a>, as it may lose its effect.\n</p>\n<h3><span class=\"mw-headline\" id=\"Special_populations\">Special populations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=3\" title=\"Edit section: Special populations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Patients at greatest risk for negative polypharmacy consequences include the <a href=\"/wiki/Elderly\" class=\"mw-redirect\" title=\"Elderly\">elderly</a>, <a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">psychiatric</a> patients, patients taking five or more drugs concurrently, those with multiple <a href=\"/wiki/Physician\" title=\"Physician\">physicians</a> and <a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">pharmacies</a>, recently hospitalized patients, individuals with concurrent <a href=\"/wiki/Comorbidity\" title=\"Comorbidity\">comorbidities</a>,<sup id=\"cite_ref-pmid16091574_18-0\" class=\"reference\"><a href=\"#cite_note-pmid16091574-18\">&#91;18&#93;</a></sup> low educational level,<sup id=\"cite_ref-pmid18343279_19-0\" class=\"reference\"><a href=\"#cite_note-pmid18343279-19\">&#91;19&#93;</a></sup> and those with impaired vision or dexterity.\n</p><p>It is not uncommon for those dependent or addicted to substances to enter or remain in a state of polypharmacy misuse. Note, however, that the term <i>polypharmacy</i> and its variants generally refer to legal drug use as-prescribed, even when used in a negative or critical context.\n</p><p>Measures can be taken to limit polypharmacy to its truly legitimate and appropriate needs. This is an emerging area of research, frequently called <a href=\"/wiki/Deprescribing\" title=\"Deprescribing\">deprescribing</a>.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> This reduction in medications has been shown to reduce the number of medications and is safe as it does not significantly alter health outcomes.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (August 2016)\">unreliable medical source?</span></a></i>&#93;</sup> Clinical pharmacists can perform drug therapy reviews and teach physicians and their patients about drug safety and polypharmacy, as well as collaborating with physicians and patients to correct polypharmacy problems. Similar programs are likely to reduce the potentially deleterious consequences of polypharmacy. Such programs hinge upon patients and doctors informing pharmacists of other medications being prescribed, as well as herbal, over-the-counter substances and supplements that occasionally interfere with prescription-only medication.\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:297px;\"><a href=\"/wiki/File:Mediciner_(Small).jpg\" class=\"image\"><img alt=\"Mediciner (Small).jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Mediciner_%28Small%29.jpg/295px-Mediciner_%28Small%29.jpg\" width=\"295\" height=\"197\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Mediciner_%28Small%29.jpg/443px-Mediciner_%28Small%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/10/Mediciner_%28Small%29.jpg/590px-Mediciner_%28Small%29.jpg 2x\" data-file-width=\"720\" data-file-height=\"480\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Mediciner_(Small).jpg\" class=\"internal\" title=\"Enlarge\"></a></div></div></div></div>\n<h3><span class=\"mw-headline\" id=\"Pill_burden\">Pill burden</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=4\" title=\"Edit section: Pill burden\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox ambox-content ambox-one_source\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"Question book-new.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>relies largely or entirely upon a <a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\">single source</a></b>.<span class=\"hide-when-compact\"> Relevant discussion may be found on the <a href=\"/wiki/Talk:Polypharmacy##\" title=\"Talk:Polypharmacy\">talk page</a>. Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Polypharmacy&amp;action=edit\">improve this article</a> by introducing <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">citations</a> to additional sources.</span>  <small><i>(March 2017)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>Pill burden is the number of pills (tablets or capsules, the most common dosage forms) that a patient takes on a regular basis, along with all associated efforts that increase with that number - like storing, organizing, consuming, and understanding the various medications in one's regimen.\n</p><p>High pill burden decreases <a href=\"/wiki/Compliance_(medicine)\" class=\"mw-redirect\" title=\"Compliance (medicine)\">compliance</a> with drug therapy, resulting from the need to take a large quantity of pills or other forms of medication on a regular basis. It also increases the possibility of adverse medication reactions (<a href=\"/wiki/Adverse_effect_(medicine)\" class=\"mw-redirect\" title=\"Adverse effect (medicine)\">side effects</a>) and <a href=\"/wiki/Drug_interaction\" title=\"Drug interaction\">drug-drug interactions</a>. High pill burden has also been associated with an increased risk of hospitalization, medication errors, and increased costs for both the pharmaceuticals themselves and for the treatment of adverse events. Finally, pill burden is a source of dissatisfaction for many patients.\n</p><p>High pill burden was once commonly associated with <a href=\"/wiki/Antiretroviral_drug\" class=\"mw-redirect\" title=\"Antiretroviral drug\">antiretroviral drug</a> regimens to control <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a>, but now is more often seen in other patient populations. For instance, adults with multiple common chronic conditions such as <a href=\"/wiki/Diabetes\" class=\"mw-redirect\" title=\"Diabetes\">diabetes</a>, <a href=\"/wiki/Hypertension\" title=\"Hypertension\">hypertension</a>, <a href=\"/wiki/Lymphedema\" title=\"Lymphedema\">lymphedema</a>, <a href=\"/wiki/Hypercholesterolemia\" title=\"Hypercholesterolemia\">hypercholesterolemia</a>, <a href=\"/wiki/Osteoporosis\" title=\"Osteoporosis\">osteoporosis</a>, <a href=\"/wiki/Constipation\" title=\"Constipation\">constipation</a>, and <a href=\"/wiki/Clinical_depression\" class=\"mw-redirect\" title=\"Clinical depression\">clinical depression</a> can often be prescribed more than a dozen different medications daily. The adverse reactions of these combinations of drugs are not reliably predictable. <a href=\"/wiki/Obesity\" title=\"Obesity\">Obesity</a> is implicated in many of the aforementioned conditions, and it is not uncommon for a clinically obese patient to receive pharmacologic treatment for all of these. Because chronic conditions tend to accumulate in the elderly, pill burden is a particular issue in <a href=\"/wiki/Geriatrics\" title=\"Geriatrics\">geriatrics</a>.\n</p><p>Reducing pill burden is recognized as a way to improve medication compliance. This is done through \"deprescribing\", where the risks and benefits are weighed when considering whether to continue a medication.<sup id=\"cite_ref-racgp.org.au_22-0\" class=\"reference\"><a href=\"#cite_note-racgp.org.au-22\">&#91;22&#93;</a></sup> This includes drugs such as bisphosphonates (for osteoporosis) where it is often used indefinitely although there is only evidence to use it for five to ten years.<sup id=\"cite_ref-racgp.org.au_22-1\" class=\"reference\"><a href=\"#cite_note-racgp.org.au-22\">&#91;22&#93;</a></sup>\n</p><p>The selection of long-acting active ingredients over short-acting ones may also reduce pill burden. For instance, <a href=\"/wiki/ACE_inhibitor\" title=\"ACE inhibitor\">ACE inhibitors</a> are used in the management of <a href=\"/wiki/Hypertension\" title=\"Hypertension\">hypertension</a>. Both <a href=\"/wiki/Captopril\" title=\"Captopril\">captopril</a> and <a href=\"/wiki/Lisinopril\" title=\"Lisinopril\">lisinopril</a> are examples of ACE inhibitors. However, lisinopril is dosed once a day, whereas captopril may be dosed 2-3 times a day. Assuming that there are no contraindications or potential for drug interactions, using lisinopril instead of captopril may be an appropriate way to limit pill burden.\n</p>\n<h2><span class=\"mw-headline\" id=\"Interventions\">Interventions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=5\" title=\"Edit section: Interventions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The most common intervention in polypharmacy patients is <a href=\"/wiki/Deprescribing\" title=\"Deprescribing\">deprescribing</a>, which includes the identification and discontinuance of medications when the benefit no longer outweighs the harm. In elderly patients, this can commonly be done as a patient becomes more frail and treatment focus needs to shift from <a href=\"/wiki/Preventive_healthcare\" title=\"Preventive healthcare\">preventative</a> to <a href=\"/wiki/Palliative_care\" title=\"Palliative care\">palliative</a>.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p><p>Several tools exist to help physicians decide when to deprescribe and what medications can be added to a <a href=\"/wiki/Pharmaceutical_drug\" class=\"mw-redirect\" title=\"Pharmaceutical drug\">pharmaceutical</a> regimen. The <a href=\"/wiki/Beers_Criteria\" title=\"Beers Criteria\">Beers Criteria</a> and the STOPP/START criteria help identify medications that have the highest risk of <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug events</a> (ADE) and <a href=\"/wiki/Drug_interaction\" title=\"Drug interaction\">drug-drug interactions</a>. PRIMA-eds is an algorithm that takes many patient factors into its calculations and can offer medication and dosing recommendations to the provider.  Parameters of PRIMA-eds include diagnoses, medications, ADEs, symptoms, <a href=\"/wiki/Body_mass_index\" title=\"Body mass index\">body mass index</a>, <a href=\"/wiki/Vital_signs\" title=\"Vital signs\">vital signs</a>, laboratory results, and medical studies performed in the elderly.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p><p>A team approach is a relatively new method gaining popularity due to its effectiveness in managing patient care and obtaining the best outcomes.  A team can include a primary provider, pharmacist, nurse, counselor, physical therapist, chaplain and others involved in patient care.  Combining the ideas and points of view of the different providers allows a more <a href=\"/wiki/Holistic_health\" class=\"mw-redirect\" title=\"Holistic health\">holistic</a> approach to the health of a patient.  In 2013, the United States legislature mandated that every <a href=\"/wiki/Medicare_Part_D\" title=\"Medicare Part D\">Medicare D</a> patient receive an annual Medication Therapy Management (MTM) review by a team of healthcare professionals.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p><p>It is unclear if specific interventions to improve adequate polypharmacy in older adults have significant clinical results,  but they seem to reduce inappropriate prescribing and medication-related problems.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> High quality evidence is needed to make any conclusions about the effects of such interventions in care homes.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=6\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Deprescribing\" title=\"Deprescribing\">Deprescribing</a></li>\n<li><a href=\"/wiki/Adverse_effect_(medicine)\" class=\"mw-redirect\" title=\"Adverse effect (medicine)\">Adverse effect</a></li>\n<li><a href=\"/wiki/Classification_of_Pharmaco-Therapeutic_Referrals\" title=\"Classification of Pharmaco-Therapeutic Referrals\">Classification of Pharmaco-Therapeutic Referrals</a></li>\n<li><a href=\"/wiki/Compliance_(medicine)\" class=\"mw-redirect\" title=\"Compliance (medicine)\">Compliance</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=7\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-ncbi.nlm.nih.gov-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ncbi.nlm.nih.gov_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Munger MA (Nov 2010). \"Polypharmacy and combination therapy in the management of hypertens\". <i>Drugs Aging</i>. <b>27</b>: 871\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/11538650-000000000-00000\">10.2165/11538650-000000000-00000</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20964461\">20964461</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs+Aging&amp;rft.atitle=Polypharmacy+and+combination+therapy+in+the+management+of+hypertens&amp;rft.volume=27&amp;rft.pages=871-83&amp;rft.date=2010-11&amp;rft_id=info%3Adoi%2F10.2165%2F11538650-000000000-00000&amp;rft_id=info%3Apmid%2F20964461&amp;rft.au=Munger+MA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-vumc.nl-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-vumc.nl_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-vumc.nl_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.vumc.nl/afdelingen-themas/41463/27797/2089686/2090096/1702335/2.pdf\">\"Polypharmacy in Elderly Patients\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Vumc.nl<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 January</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Polypharmacy+in+Elderly+Patients&amp;rft.pub=Vumc.nl&amp;rft_id=http%3A%2F%2Fwww.vumc.nl%2Fafdelingen-themas%2F41463%2F27797%2F2089686%2F2090096%2F1702335%2F2.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://medical-dictionary.thefreedictionary.com/polypharmacy\">\"polypharmacy\"</a>. <i>TheFreeDictionary.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 January</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TheFreeDictionary.com&amp;rft.atitle=polypharmacy&amp;rft_id=http%3A%2F%2Fmedical-dictionary.thefreedictionary.com%2Fpolypharmacy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stawicki, S. P.; Gerlach, A. T. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://journal.opus12.org/o12-ojs/ojs-2.1.1/index.php/o12sci/article/view/257\">\"Polypharmacy and medication errors: Stop, listen, look, and analyze...\"</a> <i>OPUS 12 Scientist</i>. <b>3</b> (1): 6\u201310.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=OPUS+12+Scientist&amp;rft.atitle=Polypharmacy+and+medication+errors%3A+Stop%2C+listen%2C+look%2C+and+analyze...&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=6-10&amp;rft.date=2009&amp;rft.aulast=Stawicki&amp;rft.aufirst=S.+P.&amp;rft.au=Gerlach%2C+A.+T.&amp;rft_id=http%3A%2F%2Fjournal.opus12.org%2Fo12-ojs%2Fojs-2.1.1%2Findex.php%2Fo12sci%2Farticle%2Fview%2F257&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18184532-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18184532_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haider, SI; Johnell, K; Thorslund, M; Fastbom, J (2007). \"Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002\". <i>International Journal of Clinical Pharmacology and Therapeutics</i>. <b>45</b> (12): 643\u2013653. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.5414/cpp45643\">10.5414/cpp45643</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18184532\">18184532</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Clinical+Pharmacology+and+Therapeutics&amp;rft.atitle=Trends+in+polypharmacy+and+potential+drug-drug+interactions+across+educational+groups+in+elderly+patients+in+Sweden+for+the+period+1992+-+2002&amp;rft.volume=45&amp;rft.issue=12&amp;rft.pages=643-653&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.5414%2Fcpp45643&amp;rft_id=info%3Apmid%2F18184532&amp;rft.aulast=Haider&amp;rft.aufirst=SI&amp;rft.au=Johnell%2C+K&amp;rft.au=Thorslund%2C+M&amp;rft.au=Fastbom%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haider, SI; Ansari, Z; Vaughan, L; Matters, H; Emerson, E. (2014). \"Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability\". <i>Research in Developmental Disabilities</i>. <b>35</b> (11): 3070\u20133080. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ridd.2014.07.060\">10.1016/j.ridd.2014.07.060</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Research+in+Developmental+Disabilities&amp;rft.atitle=Prevalence+and+factors+associated+with+polypharmacy+in+Victorian+adults+with+intellectual+disability&amp;rft.volume=35&amp;rft.issue=11&amp;rft.pages=3070-3080&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ridd.2014.07.060&amp;rft.aulast=Haider&amp;rft.aufirst=SI&amp;rft.au=Ansari%2C+Z&amp;rft.au=Vaughan%2C+L&amp;rft.au=Matters%2C+H&amp;rft.au=Emerson%2C+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19054196-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19054196_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haider, SI; Johnell, K; Weitoft, GR; Thorslund, M; Fastbom, J (2009). \"The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people\". <i>Journal of the American Geriatrics Society</i>. <b>57</b> (1): 62\u201369. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1532-5415.2008.02040.x\">10.1111/j.1532-5415.2008.02040.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19054196\">19054196</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Geriatrics+Society&amp;rft.atitle=The+influence+of+educational+level+on+polypharmacy+and+inappropriate+drug+use%3A+a+register-based+study+of+more+than+600%2C000+older+people.&amp;rft.volume=57&amp;rft.issue=1&amp;rft.pages=62-69&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1532-5415.2008.02040.x&amp;rft_id=info%3Apmid%2F19054196&amp;rft.aulast=Haider&amp;rft.aufirst=SI&amp;rft.au=Johnell%2C+K&amp;rft.au=Weitoft%2C+GR&amp;rft.au=Thorslund%2C+M&amp;rft.au=Fastbom%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ong, Gao-Jing; Page, Amy; Caughey, Gillian; Johns, Sally; Reeve, Emily; Shakib, Sepehr (2017-06-01). <a rel=\"nofollow\" class=\"external text\" href=\"https://research.monash.edu/en/publications/clinician-agreement-and-influence-of-medication-related-character\">\"Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy\"</a>. <i>Pharmacology Research &amp; Perspectives</i>. <b>5</b> (3). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/prp2.321\">10.1002/prp2.321</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+Research+%26+Perspectives&amp;rft.atitle=Clinician+agreement+and+influence+of+medication-related+characteristics+on+assessment+of+polypharmacy&amp;rft.volume=5&amp;rft.issue=3&amp;rft.date=2017-06-01&amp;rft_id=info%3Adoi%2F10.1002%2Fprp2.321&amp;rft.aulast=Ong&amp;rft.aufirst=Gao-Jing&amp;rft.au=Page%2C+Amy&amp;rft.au=Caughey%2C+Gillian&amp;rft.au=Johns%2C+Sally&amp;rft.au=Reeve%2C+Emily&amp;rft.au=Shakib%2C+Sepehr&amp;rft_id=https%3A%2F%2Fresearch.monash.edu%2Fen%2Fpublications%2Fclinician-agreement-and-influence-of-medication-related-character&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ajp.psychiatryonline.org/article.aspx?articleID=115997\">\"When Is Polypharmacy an Advantage?\"</a>. Ajp.psychiatryonline.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 January</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=When+Is+Polypharmacy+an+Advantage%3F&amp;rft.pub=Ajp.psychiatryonline.org&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Farticle.aspx%3FarticleID%3D115997&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sergi, G; De Rui, M; Sarti, S; Manzato, E (2011). \"Polypharmacy in the elderly: Can comprehensive geriatric assessment reduce inappropriate medication use?\". <i>Drugs Aging</i>. <b>28</b> (7): 509\u2013518. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/11592010-000000000-00000\">10.2165/11592010-000000000-00000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs+Aging&amp;rft.atitle=Polypharmacy+in+the+elderly%3A+Can+comprehensive+geriatric+assessment+reduce+inappropriate+medication+use%3F&amp;rft.volume=28&amp;rft.issue=7&amp;rft.pages=509-518&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.2165%2F11592010-000000000-00000&amp;rft.aulast=Sergi&amp;rft.aufirst=G&amp;rft.au=De+Rui%2C+M&amp;rft.au=Sarti%2C+S&amp;rft.au=Manzato%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">da Cruz, Ligiane Paula; Miranda, Patr\u00edcia Monforte Miranda; Vedana, Kelly Graziani; Miasso, Adriana Inocenti (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.scielo.br/pdf/rlae/v19n4/13.pdf\">\"Medication therapy: Adherence, knowledge and difficulties of elderly people from bipolar disorder\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Revista Latino-Americana De Enfermagem (RLAE)</i>. <b>19</b> (4): 944\u2013952. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1590/S0104-11692011000400013\">10.1590/S0104-11692011000400013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21876947\">21876947</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revista+Latino-Americana+De+Enfermagem+%28RLAE%29&amp;rft.atitle=Medication+therapy%3A+Adherence%2C+knowledge+and+difficulties+of+elderly+people+from+bipolar+disorder&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=944-952&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1590%2FS0104-11692011000400013&amp;rft_id=info%3Apmid%2F21876947&amp;rft.aulast=da+Cruz&amp;rft.aufirst=Ligiane+Paula&amp;rft.au=Miranda%2C+Patr%C3%ADcia+Monforte+Miranda&amp;rft.au=Vedana%2C+Kelly+Graziani&amp;rft.au=Miasso%2C+Adriana+Inocenti&amp;rft_id=http%3A%2F%2Fwww.scielo.br%2Fpdf%2Frlae%2Fv19n4%2F13.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gellad, Walid F.; Grenard, Jerry L.; Marcum, Zachary A. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3084587\">\"A systematic review of barriers to medication adherence in the elderly: Looking beyond cost and regimen complexity\"</a>. <i>American Journal of Geriatric Pharmacotherapy</i>. <b>9</b> (1): 11\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjopharm.2011.02.004\">10.1016/j.amjopharm.2011.02.004</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3084587\">3084587</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21459305\">21459305</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Geriatric+Pharmacotherapy&amp;rft.atitle=A+systematic+review+of+barriers+to+medication+adherence+in+the+elderly%3A+Looking+beyond+cost+and+regimen+complexity&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=11-23&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3084587&amp;rft_id=info%3Apmid%2F21459305&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjopharm.2011.02.004&amp;rft.aulast=Gellad&amp;rft.aufirst=Walid+F.&amp;rft.au=Grenard%2C+Jerry+L.&amp;rft.au=Marcum%2C+Zachary+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3084587&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cline, C.M.J.; Bj\u00f6rck-Linn\u00e9, A.K.; Israelsson, B.Y.A.; Willenheimer, R.B.; Erhardt, L.R. (1999-06-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.1016/S1388-9842(99)00014-8/abstract\">\"Non-compliance and knowledge of prescribed medication in elderly patients with heart failure\"</a>. <i>European Journal of Heart Failure</i>. <b>1</b> (2): 145\u2013149. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1388-9842%2899%2900014-8\">10.1016/S1388-9842(99)00014-8</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1879-0844\">1879-0844</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10937924\">10937924</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Heart+Failure&amp;rft.atitle=Non-compliance+and+knowledge+of+prescribed+medication+in+elderly+patients+with+heart+failure&amp;rft.volume=1&amp;rft.issue=2&amp;rft.pages=145-149&amp;rft.date=1999-06-01&amp;rft.issn=1879-0844&amp;rft_id=info%3Apmid%2F10937924&amp;rft_id=info%3Adoi%2F10.1016%2FS1388-9842%2899%2900014-8&amp;rft.aulast=Cline&amp;rft.aufirst=C.M.J.&amp;rft.au=Bj%C3%B6rck-Linn%C3%A9%2C+A.K.&amp;rft.au=Israelsson%2C+B.Y.A.&amp;rft.au=Willenheimer%2C+R.B.&amp;rft.au=Erhardt%2C+L.R.&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1016%2FS1388-9842%2899%2900014-8%2Fabstract&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yasein, Nada A.; Barghouti, Farihan F.; Irshaid, Yacoub M.; Suleiman, Ahmad A. (March 2013). \"Discrepancies between elderly patient's self-reported and prescribed medications: a social investigation\". <i>Scandinavian Journal of Caring Sciences</i>. <b>27</b> (1): 131\u2013138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1471-6712.2012.01012.x\">10.1111/j.1471-6712.2012.01012.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22616831\">22616831</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scandinavian+Journal+of+Caring+Sciences&amp;rft.atitle=Discrepancies+between+elderly+patient%27s+self-reported+and+prescribed+medications%3A+a+social+investigation&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=131-138&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1471-6712.2012.01012.x&amp;rft_id=info%3Apmid%2F22616831&amp;rft.aulast=Yasein&amp;rft.aufirst=Nada+A.&amp;rft.au=Barghouti%2C+Farihan+F.&amp;rft.au=Irshaid%2C+Yacoub+M.&amp;rft.au=Suleiman%2C+Ahmad+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mandell, A.J.; Selz, K.A. (1992). \"Dynamical systems in psychiatry: Now what?\". <i>Biological Psychiatry</i>. <b>32</b>: 299\u2013301. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0006-3223%2892%2990034-w\">10.1016/0006-3223(92)90034-w</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biological+Psychiatry&amp;rft.atitle=Dynamical+systems+in+psychiatry%3A+Now+what%3F&amp;rft.volume=32&amp;rft.pages=299-301&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.1016%2F0006-3223%2892%2990034-w&amp;rft.aulast=Mandell&amp;rft.aufirst=A.J.&amp;rft.au=Selz%2C+K.A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Callahan, J.; Sashin, J. I. (1987). \"Models of affect-response and anorexia nervosa\". <i>Ann. N.Y. Acad. Sci</i>. <b>504</b>: 241\u2013259. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1749-6632.1987.tb48736.x\">10.1111/j.1749-6632.1987.tb48736.x</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann.+N.Y.+Acad.+Sci.&amp;rft.atitle=Models+of+affect-response+and+anorexia+nervosa&amp;rft.volume=504&amp;rft.pages=241-259&amp;rft.date=1987&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1749-6632.1987.tb48736.x&amp;rft.aulast=Callahan&amp;rft.aufirst=J.&amp;rft.au=Sashin%2C+J.+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-PMC2702513-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMC2702513_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Qato, DM; Wilder, J; Schumm, LP; Gillet, V; Alexander, GC (2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://archinte.jamanetwork.com/article.aspx?articleid=2500064&amp;cmp=1\">\"Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011\"</a>. <i>JAMA</i>. <b>176</b> (4): 473\u2013482. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jamainternmed.2015.8581\">10.1001/jamainternmed.2015.8581</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5024734\">5024734</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26998708\">26998708</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Changes+in+Prescription+and+Over-the-Counter+Medication+and+Dietary+Supplement+Use+Among+Older+Adults+in+the+United+States%2C+2005+vs+2011&amp;rft.volume=176&amp;rft.issue=4&amp;rft.pages=473-482&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5024734&amp;rft_id=info%3Apmid%2F26998708&amp;rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2015.8581&amp;rft.aulast=Qato&amp;rft.aufirst=DM&amp;rft.au=Wilder%2C+J&amp;rft.au=Schumm%2C+LP&amp;rft.au=Gillet%2C+V&amp;rft.au=Alexander%2C+GC&amp;rft_id=http%3A%2F%2Farchinte.jamanetwork.com%2Farticle.aspx%3Farticleid%3D2500064%26cmp%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16091574-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16091574_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Boyd, CM; Darer, J; Boult, C; Fried, LP; Boult, L; Wu, AW (2005). \"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance\". <i>JAMA</i>. <b>294</b> (6): 716\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.294.6.716\">10.1001/jama.294.6.716</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16091574\">16091574</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Clinical+practice+guidelines+and+quality+of+care+for+older+patients+with+multiple+comorbid+diseases%3A+implications+for+pay+for+performance&amp;rft.volume=294&amp;rft.issue=6&amp;rft.pages=716-24&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.294.6.716&amp;rft_id=info%3Apmid%2F16091574&amp;rft.aulast=Boyd&amp;rft.aufirst=CM&amp;rft.au=Darer%2C+J&amp;rft.au=Boult%2C+C&amp;rft.au=Fried%2C+LP&amp;rft.au=Boult%2C+L&amp;rft.au=Wu%2C+AW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18343279-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18343279_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haider, SI; Johnell, K; Thorslund, M; Fastbom, J (2007). \"Analysis of the association between polypharmacy and socioeconomic position among elderly aged &gt;/=77 years in Sweden\". <i>Clin Ther</i>. <b>30</b> (2): 419\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.clinthera.2008.02.010\">10.1016/j.clinthera.2008.02.010</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18343279\">18343279</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Ther&amp;rft.atitle=Analysis+of+the+association+between+polypharmacy+and+socioeconomic+position+among+elderly+aged+%3E%2F%3D77+years+in+Sweden&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=419-27&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinthera.2008.02.010&amp;rft_id=info%3Apmid%2F18343279&amp;rft.aulast=Haider&amp;rft.aufirst=SI&amp;rft.au=Johnell%2C+K&amp;rft.au=Thorslund%2C+M&amp;rft.au=Fastbom%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Page, AT; Clifford R., M; Potter, K; Schwartz, D; Etherton\u2010Beer, CD (14 April 2016). \"The feasibility and the effect of deprescribing in older adults on mortality and health: A systematic review\". <i>British Journal of Clinical Pharmacology</i>. <b>82</b>: 583\u2013623. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bcp.12975\">10.1111/bcp.12975</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27077231\">27077231</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=The+feasibility+and+the+effect+of+deprescribing+in+older+adults+on+mortality+and+health%3A+A+systematic+review&amp;rft.volume=82&amp;rft.pages=583-623&amp;rft.date=2016-04-14&amp;rft_id=info%3Adoi%2F10.1111%2Fbcp.12975&amp;rft_id=info%3Apmid%2F27077231&amp;rft.aulast=Page&amp;rft.aufirst=AT&amp;rft.au=Clifford+R.%2C+M&amp;rft.au=Potter%2C+K&amp;rft.au=Schwartz%2C+D&amp;rft.au=Etherton%E2%80%90Beer%2C+CD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Potter, Kathleen; Flicker, Leon; Page, Amy; Etherton-Beer, Christopher (4 March 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149984\">\"Deprescribing in frail older people: a randomised controlled trial\"</a>. <i>PLOS ONE</i>. <b>11</b> (3): e0149984. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pone.0149984\">10.1371/journal.pone.0149984</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4778763\">4778763</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26942907\">26942907</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Deprescribing+in+frail+older+people%3A+a+randomised+controlled+trial.&amp;rft.volume=11&amp;rft.issue=3&amp;rft.pages=e0149984&amp;rft.date=2016-03-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4778763&amp;rft_id=info%3Apmid%2F26942907&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0149984&amp;rft.aulast=Potter&amp;rft.aufirst=Kathleen&amp;rft.au=Flicker%2C+Leon&amp;rft.au=Page%2C+Amy&amp;rft.au=Etherton-Beer%2C+Christopher&amp;rft_id=http%3A%2F%2Fjournals.plos.org%2Fplosone%2Farticle%3Fid%3D10.1371%2Fjournal.pone.0149984&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-racgp.org.au-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-racgp.org.au_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-racgp.org.au_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hilmer, Sarah N.; Gnjidic, Danijela; Le Couteur, David G. (December 2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.racgp.org.au/afp/2012/december/medication-list/\">\"Thinking through the medication list: appropriate prescribing and deprescribing in robust and frail older patients\"</a>. <i>Australian Family Physician</i>. <b>41</b> (12): 924\u2013928. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23210113\">23210113</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Australian+Family+Physician&amp;rft.atitle=Thinking+through+the+medication+list%3A+appropriate+prescribing+and+deprescribing+in+robust+and+frail+older+patients.&amp;rft.volume=41&amp;rft.issue=12&amp;rft.pages=924-928&amp;rft.date=2012-12&amp;rft_id=info%3Apmid%2F23210113&amp;rft.aulast=Hilmer&amp;rft.aufirst=Sarah+N.&amp;rft.au=Gnjidic%2C+Danijela&amp;rft.au=Le+Couteur%2C+David+G.&amp;rft_id=http%3A%2F%2Fwww.racgp.org.au%2Fafp%2F2012%2Fdecember%2Fmedication-list%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cadogan, Cathal A.; Ryan, Crist\u00edn; Hughes, Carmel M. (2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4735229\">\"Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many\"</a>. <i>Drug Safety</i>. <b>39</b> (2): 109\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40264-015-0378-5\">10.1007/s40264-015-0378-5</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4735229\">4735229</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26692396\">26692396</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Safety&amp;rft.atitle=Appropriate+Polypharmacy+and+Medicine+Safety%3A+When+Many+is+not+Too+Many&amp;rft.volume=39&amp;rft.issue=2&amp;rft.pages=109-16&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4735229&amp;rft_id=info%3Apmid%2F26692396&amp;rft_id=info%3Adoi%2F10.1007%2Fs40264-015-0378-5&amp;rft.aulast=Cadogan&amp;rft.aufirst=Cathal+A.&amp;rft.au=Ryan%2C+Crist%C3%ADn&amp;rft.au=Hughes%2C+Carmel+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4735229&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">S\u00f6nnichsen, Andreas; Trampisch, Ulrike S.; Rieckert, Anja; Piccoliori, Giuliano; V\u00f6gele, Anna; Flamm, Maria; Johansson, Tim; Esmail, Aneez; Reeves, David; L\u00f6ffler, Christin; H\u00f6ck, Jennifer; Klaassen-Mielke, Renate; Trampisch, Hans Joachim; Kunnamo, Ilkka (29 January 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1177-8\">\"Polypharmacy in Chronic Diseases \u2013 Reduction of Inappropriate Medication and Adverse Drug Events in Older Populations by Electronic Decision Support (PRIMA-eDS): Study Protocol for a Randomized Controlled Trial\"</a>. <i>Trials</i>. <b>17</b> (57). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/s13063-016-1177-8\">10.1186/s13063-016-1177-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26822311\">26822311</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 15,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trials&amp;rft.atitle=Polypharmacy+in+Chronic+Diseases+%E2%80%93+Reduction+of+Inappropriate+Medication+and+Adverse+Drug+Events+in+Older+Populations+by+Electronic+Decision+Support+%28PRIMA-eDS%29%3A+Study+Protocol+for+a+Randomized+Controlled+Trial&amp;rft.volume=17&amp;rft.issue=57&amp;rft.date=2016-01-29&amp;rft_id=info%3Adoi%2F10.1186%2Fs13063-016-1177-8&amp;rft_id=info%3Apmid%2F26822311&amp;rft.aulast=S%C3%B6nnichsen&amp;rft.aufirst=Andreas&amp;rft.au=Trampisch%2C+Ulrike+S.&amp;rft.au=Rieckert%2C+Anja&amp;rft.au=Piccoliori%2C+Giuliano&amp;rft.au=V%C3%B6gele%2C+Anna&amp;rft.au=Flamm%2C+Maria&amp;rft.au=Johansson%2C+Tim&amp;rft.au=Esmail%2C+Aneez&amp;rft.au=Reeves%2C+David&amp;rft.au=L%C3%B6ffler%2C+Christin&amp;rft.au=H%C3%B6ck%2C+Jennifer&amp;rft.au=Klaassen-Mielke%2C+Renate&amp;rft.au=Trampisch%2C+Hans+Joachim&amp;rft.au=Kunnamo%2C+Ilkka&amp;rft_id=http%3A%2F%2Ftrialsjournal.biomedcentral.com%2Farticles%2F10.1186%2Fs13063-016-1177-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Open_access\" title=\"open access publication \u2013 free to read\"><img alt=\"open access publication \u2013 free to read\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Maher et. al. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3864987\">\"Clinical Consequences of Polypharmacy in Elderly\"</a>. <i>Expert Opinion on Drug Safety</i>. <b>13</b> (1): 57\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/14740338.2013.827660\">10.1517/14740338.2013.827660</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3864987\">3864987</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24073682\">24073682</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Safety&amp;rft.atitle=Clinical+Consequences+of+Polypharmacy+in+Elderly&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=57-65&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3864987&amp;rft_id=info%3Apmid%2F24073682&amp;rft_id=info%3Adoi%2F10.1517%2F14740338.2013.827660&amp;rft.au=Maher+et.+al.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3864987&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Patterson, Susan M.; Cadogan, Cathal A.; Kerse, Ngaire; Cardwell, Chris R.; Bradley, Marie C.; Ryan, Cristin; Hughes, Carmel (2014-10-07). \"Interventions to improve the appropriate use of polypharmacy for older people\". <i>The Cochrane Database of Systematic Reviews</i> (10): CD008165. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD008165.pub3\">10.1002/14651858.CD008165.pub3</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1469-493X\">1469-493X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25288041\">25288041</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interventions+to+improve+the+appropriate+use+of+polypharmacy+for+older+people&amp;rft.issue=10&amp;rft.pages=CD008165&amp;rft.date=2014-10-07&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F25288041&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008165.pub3&amp;rft.aulast=Patterson&amp;rft.aufirst=Susan+M.&amp;rft.au=Cadogan%2C+Cathal+A.&amp;rft.au=Kerse%2C+Ngaire&amp;rft.au=Cardwell%2C+Chris+R.&amp;rft.au=Bradley%2C+Marie+C.&amp;rft.au=Ryan%2C+Cristin&amp;rft.au=Hughes%2C+Carmel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alldred, David P.; Kennedy, Mary-Claire; Hughes, Carmel; Chen, Timothy F.; Miller, Paul (2016-02-12). \"Interventions to optimise prescribing for older people in care homes\". <i>The Cochrane Database of Systematic Reviews</i>. <b>2</b>: CD009095. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD009095.pub3\">10.1002/14651858.CD009095.pub3</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1469-493X\">1469-493X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26866421\">26866421</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interventions+to+optimise+prescribing+for+older+people+in+care+homes&amp;rft.volume=2&amp;rft.pages=CD009095&amp;rft.date=2016-02-12&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F26866421&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009095.pub3&amp;rft.aulast=Alldred&amp;rft.aufirst=David+P.&amp;rft.au=Kennedy%2C+Mary-Claire&amp;rft.au=Hughes%2C+Carmel&amp;rft.au=Chen%2C+Timothy+F.&amp;rft.au=Miller%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=8\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r853264625\">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class=\"refbegin\" style=\"\">\n<ul><li><cite class=\"citation journal\">Golchin N, Frank SH, Vince A, Isham L, Meropol SB (April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4418141\">\"Polypharmacy in the elderly\"</a>. <i>Journal of Research in Pharmacy Practice</i>. <b>4</b> (2): 85\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4103/2279-042X.155755\">10.4103/2279-042X.155755</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4418141\">4418141</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25984546\">25984546</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Research+in+Pharmacy+Practice&amp;rft.atitle=Polypharmacy+in+the+elderly&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=85-8&amp;rft.date=2015-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4418141&amp;rft_id=info%3Apmid%2F25984546&amp;rft_id=info%3Adoi%2F10.4103%2F2279-042X.155755&amp;rft.aulast=Golchin&amp;rft.aufirst=N&amp;rft.au=Frank%2C+SH&amp;rft.au=Vince%2C+A&amp;rft.au=Isham%2C+L&amp;rft.au=Meropol%2C+SB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4418141&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APolypharmacy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Polypharmacy&amp;action=edit&amp;section=9\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/American_Nurses_Association\" title=\"American Nurses Association\">American Nurses Association</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ana.org/readroom/position/drug/drpoly.htm\">Position Statement on Polypharmacy and the Older Adult</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20050320203853/http://www.nasmhpd.org/general_files/publications/med_directors_pubs/Polypharmacy.PDF\">NASMHPD.org (pdf)</a> - 'Technical Report on Psychiatric Polypharmacy', National Association of State Mental Health Program Directors, (October 9, 2001)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://psychrights.org/Articles/PAICAonPolypharmacy.htm\">PsychRights.org</a> - 'Psychiatric Polypharmacy: A Word of Caution', Leslie Morrison, MS, RN, Esq, Paul B. Duryea, Charis Moore, Alexandra Nathanson-Shinn, Stephen E. Hall, MD, James Meeker, PhD, DABFT, Charles A. Reynolds, PharmD, BCPP, Protection &amp; Advocacy, Inc.</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081202174240/http://prescriptions.bsd.uchicago.edu/Polypharmacy/index.html\">\"Polypharmacy in Older Adults: Information for people who are taking several medications\"</a>, <a href=\"/wiki/University_of_North_Carolina_at_Chapel_Hill\" title=\"University of North Carolina at Chapel Hill\">University of North Carolina at Chapel Hill</a> School of Medicine</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.central.knowledge.scot.nhs.uk/upload/Polypharmacy%20full%20guidance%20v2.pdf\">- \"Appropriate Prescribing for Patients and Polypharmacy Guidance for Review of Quality, Safe and Effective Use of Long-term Medication.\" Scotland NHS, 2012</a></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Unnecessary_health_care\" style=\"padding:3px\"><table class=\"nowraplinks collapsible expanded navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Unnecessary_health_care\" title=\"Template:Unnecessary health care\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Unnecessary_health_care\" title=\"Template talk:Unnecessary health care\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Unnecessary_health_care&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Unnecessary_health_care\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Unnecessary_health_care\" title=\"Unnecessary health care\">Unnecessary health care</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Causes</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Direct-to-consumer_advertising\" title=\"Direct-to-consumer advertising\">Direct-to-consumer advertising</a></li>\n<li><a href=\"/wiki/Overscreening\" title=\"Overscreening\">Overscreening</a></li>\n<li><a href=\"/wiki/Overdiagnosis\" title=\"Overdiagnosis\">Overdiagnosis</a></li>\n<li><a href=\"/wiki/Fee-for-service\" title=\"Fee-for-service\">Fee-for-service</a></li>\n<li><a href=\"/wiki/Defensive_medicine\" title=\"Defensive medicine\">Defensive medicine</a></li>\n<li><a href=\"/wiki/Unwarranted_variation\" title=\"Unwarranted variation\">Unwarranted variation</a></li>\n<li><a href=\"/wiki/Overmedication\" title=\"Overmedication\">Overmedication</a></li>\n<li><a href=\"/wiki/Disease_mongering\" title=\"Disease mongering\">Disease mongering</a></li>\n<li><a href=\"/wiki/Political_abuse_of_psychiatry\" title=\"Political abuse of psychiatry\">Political abuse of psychiatry</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Overused health care</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Caesarean_delivery_on_maternal_request\" title=\"Caesarean delivery on maternal request\">Caesarean delivery on maternal request</a></li>\n<li><a href=\"/wiki/Antibiotic_misuse\" title=\"Antibiotic misuse\">Antibiotic misuse</a></li>\n<li><a class=\"mw-selflink selflink\">Polypharmacy</a></li>\n<li>treatment of <a href=\"/wiki/Incidentaloma\" class=\"mw-redirect\" title=\"Incidentaloma\">incidentaloma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Works about unnecessary health care</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Overtreated\" title=\"Overtreated\">Overtreated</a></i></li>\n<li><i><a href=\"/wiki/The_Treatment_Trap\" title=\"The Treatment Trap\">The Treatment Trap</a></i></li>\n<li><i><a href=\"/wiki/Selling_Sickness\" title=\"Selling Sickness\">Selling Sickness</a></i></li>\n<li><i><a href=\"/wiki/Overdosed_America\" title=\"Overdosed America\">Overdosed America</a></i></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2233\nCached time: 20180913095124\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.348 seconds\nReal time usage: 0.411 seconds\nPreprocessor visited node count: 1836/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 77467/2097152 bytes\nTemplate argument size: 662/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 3/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 44452/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.174/10.000 seconds\nLua memory usage: 3.86 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  322.487      1 -total\n 66.17%  213.374      1 Template:Reflist\n 48.81%  157.397     25 Template:Cite_journal\n 18.76%   60.491      1 Template:Unreliable_medical_source\n 11.91%   38.401      1 Template:Fix\n  7.64%   24.624      1 Template:Category_handler\n  4.43%   14.290      1 Template:One_source_section\n  3.83%   12.346      1 Template:Refbegin\n  3.64%   11.729      3 Template:Cite_web\n  3.36%   10.849      1 Template:Ambox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1099391-0!canonical and timestamp 20180913095124 and revision id 844625015\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AA%D8%B9%D8%AF%D9%8A%D8%AF_%D8%A7%D9%84%D8%A3%D8%AF%D9%88%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062a\u0639\u062f\u064a\u062f \u0627\u0644\u0623\u062f\u0648\u064a\u0629"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Polypragmasie","langname":"Czech","autonym":"\u010de\u0161tina","*":"Polypragmasie"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Polypharmazie","langname":"German","autonym":"Deutsch","*":"Polypharmazie"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Paciente_polimedicado","langname":"Spanish","autonym":"espa\u00f1ol","*":"Paciente polimedicado"},{"lang":"eu","url":"https://eu.wikipedia.org/wiki/Polimedikazio","langname":"Basque","autonym":"euskara","*":"Polimedikazio"},{"lang":"is","url":"https://is.wikipedia.org/wiki/Lyfjaofgj%C3%B6f","langname":"Icelandic","autonym":"\u00edslenska","*":"Lyfjaofgj\u00f6f"},{"lang":"la","url":"https://la.wikipedia.org/wiki/Polypharmacia","langname":"Latin","autonym":"Latina","*":"Polypharmacia"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Polyfarmacie","langname":"Dutch","autonym":"Nederlands","*":"Polyfarmacie"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E5%A4%9A%E5%89%A4%E4%BD%B5%E7%94%A8","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u591a\u5264\u4f75\u7528"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Polyfarmasi","langname":"Norwegian","autonym":"norsk","*":"Polyfarmasi"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Polipragmazja","langname":"Polish","autonym":"polski","*":"Polipragmazja"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_August_2016"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_March_2017"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","*":"Pharmacokinetics"},{"sortkey":"","*":"Pharmacy"},{"sortkey":"","*":"Unnecessary_health_care"}],"links":[{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from August 2016"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from March 2017"},{"ns":1,"exists":"","*":"Talk:Polypharmacy"},{"ns":0,"exists":"","*":"Open access"},{"ns":0,"exists":"","*":"ACE inhibitor"},{"ns":0,"exists":"","*":"Activities of daily living"},{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Adverse effect (medicine)"},{"ns":0,"exists":"","*":"American Nurses Association"},{"ns":0,"exists":"","*":"Antibiotic misuse"},{"ns":0,"exists":"","*":"Antidepressant"},{"ns":0,"exists":"","*":"Antiretroviral drug"},{"ns":0,"exists":"","*":"Aspirin"},{"ns":0,"exists":"","*":"Baby-boomer"},{"ns":0,"exists":"","*":"Beers Criteria"},{"ns":0,"exists":"","*":"Beta-blocker"},{"ns":0,"exists":"","*":"Body mass index"},{"ns":0,"exists":"","*":"Caesarean delivery on maternal request"},{"ns":0,"exists":"","*":"Captopril"},{"ns":0,"exists":"","*":"Classification of Pharmaco-Therapeutic Referrals"},{"ns":0,"exists":"","*":"Clinical depression"},{"ns":0,"exists":"","*":"Cognition"},{"ns":0,"exists":"","*":"Comorbidity"},{"ns":0,"exists":"","*":"Compliance (medicine)"},{"ns":0,"exists":"","*":"Constipation"},{"ns":0,"exists":"","*":"Correlation and dependence"},{"ns":0,"exists":"","*":"Defensive medicine"},{"ns":0,"exists":"","*":"Deprescribing"},{"ns":0,"exists":"","*":"Diabetes"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Direct-to-consumer advertising"},{"ns":0,"exists":"","*":"Disease mongering"},{"ns":0,"exists":"","*":"Drug interaction"},{"ns":0,"exists":"","*":"Elderly"},{"ns":0,"exists":"","*":"Fee-for-service"},{"ns":0,"exists":"","*":"Genome"},{"ns":0,"exists":"","*":"Geriatrics"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"Health professional"},{"ns":0,"exists":"","*":"Holistic health"},{"ns":0,"exists":"","*":"Hypercholesterolemia"},{"ns":0,"exists":"","*":"Hypertension"},{"ns":0,"exists":"","*":"Incidentaloma"},{"ns":0,"exists":"","*":"Information silo"},{"ns":0,"exists":"","*":"Intellectual disability"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Interventionism (medicine)"},{"ns":0,"exists":"","*":"Life expectancy"},{"ns":0,"exists":"","*":"Lisinopril"},{"ns":0,"exists":"","*":"Lymphedema"},{"ns":0,"exists":"","*":"Medicare Part D"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"Osteoporosis"},{"ns":0,"exists":"","*":"Overdiagnosis"},{"ns":0,"exists":"","*":"Overdosed America"},{"ns":0,"exists":"","*":"Overmedication"},{"ns":0,"exists":"","*":"Overscreening"},{"ns":0,"exists":"","*":"Overtreated"},{"ns":0,"exists":"","*":"Palliative care"},{"ns":0,"exists":"","*":"Paracetamol"},{"ns":0,"exists":"","*":"Patient"},{"ns":0,"exists":"","*":"Pharmaceutical drug"},{"ns":0,"exists":"","*":"Pharmacokinetics"},{"ns":0,"exists":"","*":"Pharmacology"},{"ns":0,"exists":"","*":"Pharmacy"},{"ns":0,"exists":"","*":"Physician"},{"ns":0,"exists":"","*":"Political abuse of psychiatry"},{"ns":0,"exists":"","*":"Population ageing"},{"ns":0,"exists":"","*":"Prescribing cascade"},{"ns":0,"exists":"","*":"Preventive healthcare"},{"ns":0,"exists":"","*":"Primum non nocere"},{"ns":0,"exists":"","*":"Psychiatry"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quality of life"},{"ns":0,"exists":"","*":"Risk\u2013benefit ratio"},{"ns":0,"exists":"","*":"Selling Sickness"},{"ns":0,"exists":"","*":"Statin"},{"ns":0,"exists":"","*":"The Treatment Trap"},{"ns":0,"exists":"","*":"Transitional care"},{"ns":0,"exists":"","*":"University of North Carolina at Chapel Hill"},{"ns":0,"exists":"","*":"Unnecessary health care"},{"ns":0,"exists":"","*":"Unwarranted variation"},{"ns":0,"exists":"","*":"Vital signs"},{"ns":0,"exists":"","*":"Warfarin"},{"ns":10,"exists":"","*":"Template:Unnecessary health care"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources (medicine)"},{"ns":11,"exists":"","*":"Template talk:Unnecessary health care"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Unreliable medical source"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:One source section"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Open access"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Refbegin"},{"ns":10,"exists":"","*":"Template:Refbegin/styles.css"},{"ns":10,"exists":"","*":"Template:Refend"},{"ns":10,"exists":"","*":"Template:Unnecessary health care"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Lock-green.svg","Open_Access_logo_PLoS_transparent.svg","Methylphenidat_generics_germany.jpg","Mediciner_(Small).jpg","Question_book-new.svg"],"externallinks":["//doi.org/10.2165/11538650-000000000-00000","//www.ncbi.nlm.nih.gov/pubmed/20964461","http://www.vumc.nl/afdelingen-themas/41463/27797/2089686/2090096/1702335/2.pdf","http://medical-dictionary.thefreedictionary.com/polypharmacy","http://journal.opus12.org/o12-ojs/ojs-2.1.1/index.php/o12sci/article/view/257","//doi.org/10.5414/cpp45643","//www.ncbi.nlm.nih.gov/pubmed/18184532","//doi.org/10.1016/j.ridd.2014.07.060","//doi.org/10.1111/j.1532-5415.2008.02040.x","//www.ncbi.nlm.nih.gov/pubmed/19054196","https://research.monash.edu/en/publications/clinician-agreement-and-influence-of-medication-related-character","//doi.org/10.1002/prp2.321","http://ajp.psychiatryonline.org/article.aspx?articleID=115997","//doi.org/10.2165/11592010-000000000-00000","http://www.scielo.br/pdf/rlae/v19n4/13.pdf","//doi.org/10.1590/S0104-11692011000400013","//www.ncbi.nlm.nih.gov/pubmed/21876947","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3084587","//doi.org/10.1016/j.amjopharm.2011.02.004","//www.ncbi.nlm.nih.gov/pubmed/21459305","http://onlinelibrary.wiley.com/doi/10.1016/S1388-9842(99)00014-8/abstract","//doi.org/10.1016/S1388-9842(99)00014-8","//www.worldcat.org/issn/1879-0844","//www.ncbi.nlm.nih.gov/pubmed/10937924","//doi.org/10.1111/j.1471-6712.2012.01012.x","//www.ncbi.nlm.nih.gov/pubmed/22616831","//doi.org/10.1016/0006-3223(92)90034-w","//doi.org/10.1111/j.1749-6632.1987.tb48736.x","http://archinte.jamanetwork.com/article.aspx?articleid=2500064&cmp=1","//doi.org/10.1001/jamainternmed.2015.8581","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5024734","//www.ncbi.nlm.nih.gov/pubmed/26998708","//doi.org/10.1001/jama.294.6.716","//www.ncbi.nlm.nih.gov/pubmed/16091574","//doi.org/10.1016/j.clinthera.2008.02.010","//www.ncbi.nlm.nih.gov/pubmed/18343279","//doi.org/10.1111/bcp.12975","//www.ncbi.nlm.nih.gov/pubmed/27077231","http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149984","//doi.org/10.1371/journal.pone.0149984","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4778763","//www.ncbi.nlm.nih.gov/pubmed/26942907","http://www.racgp.org.au/afp/2012/december/medication-list/","//www.ncbi.nlm.nih.gov/pubmed/23210113","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4735229","//doi.org/10.1007/s40264-015-0378-5","//www.ncbi.nlm.nih.gov/pubmed/26692396","http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1177-8","//doi.org/10.1186/s13063-016-1177-8","//www.ncbi.nlm.nih.gov/pubmed/26822311","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3864987","//doi.org/10.1517/14740338.2013.827660","//www.ncbi.nlm.nih.gov/pubmed/24073682","//doi.org/10.1002/14651858.CD008165.pub3","//www.worldcat.org/issn/1469-493X","//www.ncbi.nlm.nih.gov/pubmed/25288041","//doi.org/10.1002/14651858.CD009095.pub3","//www.ncbi.nlm.nih.gov/pubmed/26866421","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4418141","//doi.org/10.4103/2279-042X.155755","//www.ncbi.nlm.nih.gov/pubmed/25984546","http://www.ana.org/readroom/position/drug/drpoly.htm","https://web.archive.org/web/20050320203853/http://www.nasmhpd.org/general_files/publications/med_directors_pubs/Polypharmacy.PDF","http://psychrights.org/Articles/PAICAonPolypharmacy.htm","https://web.archive.org/web/20081202174240/http://prescriptions.bsd.uchicago.edu/Polypharmacy/index.html","http://www.central.knowledge.scot.nhs.uk/upload/Polypharmacy%20full%20guidance%20v2.pdf"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Polypharmacy","byteoffset":8714,"anchor":"Medical_uses"},{"toclevel":1,"level":"2","line":"Contraindications","number":"2","index":"2","fromtitle":"Polypharmacy","byteoffset":10744,"anchor":"Contraindications"},{"toclevel":2,"level":"3","line":"Special populations","number":"2.1","index":"3","fromtitle":"Polypharmacy","byteoffset":13010,"anchor":"Special_populations"},{"toclevel":2,"level":"3","line":"Pill burden","number":"2.2","index":"4","fromtitle":"Polypharmacy","byteoffset":16345,"anchor":"Pill_burden"},{"toclevel":1,"level":"2","line":"Interventions","number":"3","index":"5","fromtitle":"Polypharmacy","byteoffset":19483,"anchor":"Interventions"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"6","fromtitle":"Polypharmacy","byteoffset":23877,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"7","fromtitle":"Polypharmacy","byteoffset":24052,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"6","index":"8","fromtitle":"Polypharmacy","byteoffset":24080,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"9","fromtitle":"Polypharmacy","byteoffset":24396,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Polypharmacy","iwlinks":[],"properties":[{"name":"newsectionlink","*":""},{"name":"wikibase_item","*":"Q1895998"}]}}